Biocryst Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights
Biocryst Pharmaceuticals Inc share price today is $10.04, up -1.12%. The stock opened at $9.77 against the previous close of $9.81, with an intraday high of $10.31 and low of $9.64.
Biocryst Pharmaceuticals Inc Share Price Chart
Biocryst Pharmaceuticals Inc
Biocryst Pharmaceuticals Inc Share Price Performance
Biocryst Pharmaceuticals Inc Institutional Holdings
Biocryst Pharmaceuticals Inc Market Status
Biocryst Pharmaceuticals Inc Fundamentals
Market Cap 1872.69 M
PB Ratio 56.5858
PE Ratio 0.0
Enterprise Value 2601.91 M
Total Assets 514.16 M
Volume 13148754
Biocryst Pharmaceuticals Inc Company Financials
About Biocryst Pharmaceuticals Inc & investment objective
Company Information BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat HAE. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in phase 1; Avoralstat, an ocular plasma kallikrein inhibitor for diabetic macular edema that is in Phase 1; Navenibart, a monoclonal antibody plasma kallikrein inhibitor for HAE which is in Phase 3; BCX17725, an investigational protein therapeutic KLK5 inhibitor for the treatment of netherton syndrome that is in phase 1 clinical trial; STAR-0310, a monoclonal antibody OX40 antagonist for the treatment of atopic dermatitis which is in Phase 1a trial. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd., Shionogi & Co., Ltd., and Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Organisation Drug Manufacturers - Specialty & Generic
Employees 435
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Charles K. Gayer
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Biocryst Pharmaceuticals Inc FAQs
What is the share price of Biocryst Pharmaceuticals Inc today?
The current share price of Biocryst Pharmaceuticals Inc is $10.04.
Can I buy Biocryst Pharmaceuticals Inc shares in India?
Yes, Indian investors can buy Biocryst Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Biocryst Pharmaceuticals Inc shares in India?
You can easily invest in Biocryst Pharmaceuticals Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Biocryst Pharmaceuticals Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Biocryst Pharmaceuticals Inc.
Can I buy fractional shares of Biocryst Pharmaceuticals Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Biocryst Pharmaceuticals Inc?
Biocryst Pharmaceuticals Inc has a market cap of $1872.69 M.
In which sector does Biocryst Pharmaceuticals Inc belong?
Biocryst Pharmaceuticals Inc operates in the Drug Manufacturers - Specialty & Generic sector.
What documents are required to invest in Biocryst Pharmaceuticals Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Biocryst Pharmaceuticals Inc?
The PE ratio of Biocryst Pharmaceuticals Inc is N/A and the PB ratio is 56.59.